Michaela Friedrichsen

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19.

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19.

Journal: European journal of immunology
Published: May 02, 2024

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.

Journal: The Lancet. Infectious diseases
Published: October 12, 2023

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.

Journal: EBioMedicine
Published: August 24, 2023

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Journal: Frontiers in immunology
Published: February 15, 2023

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Journal: Frontiers in immunology
Published: January 26, 2022

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Journal: Nature communications
Published: December 24, 2021

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Journal: Cellular & molecular immunology
Published: July 29, 2021

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Journal: Nature medicine
Published: June 01, 2021

Targeted delivery of regulatory macrophages to lymph nodes interferes with T cell priming by preventing the formation of stable immune synapses.

Targeted delivery of regulatory macrophages to lymph nodes interferes with T cell priming by preventing the formation of stable immune synapses.

Journal: Cell reports
Published: May 22, 2020

Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.

Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.

Journal: Cellular & molecular immunology
Published: April 21, 2020

Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance.

Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance.

Journal: Nature communications
Published: May 03, 2019

The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.

The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.

Journal: Cellular & molecular immunology
Published: March 14, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026